Evommune is a United States biotechnology company focused on developing therapies for chronic inflammatory diseases. Its research programs target immune pathways involved in dermatological and other immune-mediated conditions.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!